;

HESA Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Committee Report

PDF

APPENDIX A
LIST OF WITNESSES

Organizations and Individuals	Date	Meeting

Department of Health Meena Ballantyne, Assistant Deputy Minister, Health Products and Food Branch	2008/01/31	9
Diana Dowthwaite, Director General, Health Products and Food Branch Inspectorate
David K. Lee, Director, Office of Patented Medicines and Liaison, Therapeutic Products Directorate
Chris Turner, Director General, Marketed Health Products Directorate
Michael Vandergrift, Director General, Policy, Planning and International Affairs Directorate

BIOTECanada Philip Schwab, Vice-President of Industry Relations	2008/02/05	10

Canada's Research-Based Pharmaceutical Companies (Rx & D) Pier-Giorgio Fontana, Consultant, Regulatory Affairs

Canadian Generic Pharmaceutical Association Jacqueline Conant, Principal Consultant, Pharmacovigilance, Apotex Inc.
Colin D'Cunha, Director, Pharmacovigilance, Apotex Inc.

NDMAC David Skinner, President
Robert White, Director, Scientific and Regulatory Affairs

Canadian Institute for Health Information Michael Hunt, Manager, Pharmaceuticals	2008/02/07	11
Glenda Yeates, President and Chief Executive Officer

Patented Medicine Prices Review Board Brien G. Benoit, Chairperson
Barbara Ouellet, Executive Director

Canadian Pharmacists Association Jeff Poston, Executive Director	2008/02/14	13
Denis Villeneuve, Member of the Board

Canadian Society of Hospital Pharmacists Myrella Roy, Executive Director

National Association of Pharmacy Regulatory Authorities Karen Wolfe, Executive Director

Ordre des pharmaciens du Québec Claude Gagnon, President
Manon Lambert, Director General and Secretary

Canadian Medical Association John Haggie, Chair, Board Working Group on Pharmaceutical Issues	2008/02/28	14
Samuel Shortt, Director, Knowledge Transfer and Practice Policy

Canadian Men in Nursing Group Irfan Aslam, Vice President and Director of Finance
James D'Astolfo, President and Founder

Federation of Medical Regulatory Authorities of Canada Douglas Anderson, President Elect
Fleur-Ange Lefebvre, Executive Director and Chief Executive Officer

Ontario Ministry of Community Safety and Correctional Services Andrew McCallum, Regional Supervising Coroner for Eastern Ontario, Office of the Chief Coroner

Best Medicines Coalition Gail Attara, Member, Steering Committee	2008/03/06	16
Linda Wilhelm, Vice-Chair, Operations Committee

Canadian Health Coalition Michèle Brill-Edwards, Board Member

Drug Safety Canada Terence Young, Chair	2008/03/06	16

Cancer Advocacy Coalition of Canada James Gowing, Chair of the Board	2008/03/11	17
William Hryniuk, Past Chair

Expert Advisory Committee on the Vigilance of Health Products Diane Brideau-Laughlin, Chair

Institute for Safe Medication Practices Canada Sylvia Hyland, Vice President

Université de Montréal Yola Moride, Associate Professor, Faculty of Pharmacy

Anemia Institute for Research and Education Durhane Wong-Rieger, President and Chief Executive Officer	2008/03/13	18

Consumers' Association of Canada Mel Fruitman, Vice-President

PharmaWatch Colleen Fuller, President
Carol Kushner, Director

Canadian Women's Health Network Madeline Boscoe, Executive Director	2008/04/01	19

University of British Columbia Bruce Carleton, Senior Clinician Scientist, Child and Family Research Institute, BC Children's Hospital

As an individual Patrick Orr, Lawyer	2008/04/08	21

St. Michael's Hospital Andreas Laupacis, Executive Director, Li Ka Shing Knowledge Institute

University of British Columbia Steve Morgan, Assistant Professor, Centre for Health Services and Policy Research

Canada Health Infoway Richard Alvarez, President and Chief Executive Officer	2008/04/10	22
Mike Sheridan, Chief Operating Officer

Office of the Auditor General of Canada Sheila Fraser, Auditor General of Canada
Neil Maxwell, Assistant Auditor General

Office of the Privacy Commissioner of Canada Patricia Kosseim, General Counsel
Jennifer Stoddart, Privacy Commissioner

McGill University Robyn Tamblyn, Scientific Director, Clinical and Health Informatics Research, Department of Medicine	2008/04/15	23

University of Victoria Alan Cassels, Pharmaceutical Policy Researcher, School of Health Information Sciences

York University Mary Wiktorowicz, Chair and Associate Professor, School of Health Policy and Management

As individuals Julie-Kim Godin, Attorney, Ménard, Martin, Avocats	2008/04/29	25
Jean-Pierre Ménard, Attorney and Specialist in Medical Law, Ménard, Martin, Avocats

Brogan Inc. Tom Brogan, President and Chief Executive Officer

U.S. Food and Drug Administration Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research

Department of Health Marc Berthiaume, Director, Marketed Pharmaceuticals and Medical Devices Bureau, Marketed Health Products Directorate, Health Products and Food Branch	2008/05/01	26
David Clapin, Branch Science Advisor, Office of Science and Risk Management, Health Products and Food Branch
David K. Lee, Director, Office of Patented Medicines and Liaison, Therapeutic Products Directorate
Michael Vandergrift, Director General, Policy, Planning and International Affairs Directorate, Health Products and Food Branch

Ontario Ministry of Health and Long-Term Care Brent Fraser, Director, Drug Program Services Branch

Public Health Agency of Canada Barbara Law, Interim Director, Vaccine Preventable Diseases Prevention and Vaccine Safety

University of British Columbia Bruce Carleton, Senior Clinician Scientist, Child and Family Research Institute, BC Children's Hospital